Skip to main content
Gerald Edelman, MD, Oncology, Arlington, TX

GeraldEdelmanMD

Oncology Arlington, TX

Physician

Are you Dr. Edelman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 9 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    801 W Interstate 20
    Ste 132
    Arlington, TX 76017
    Phone+1 682-274-8181
    Fax+1 817-764-0175

Summary

  • Dr. Gerald Edelman, MD is an oncologist in Arlington, Texas. He is currently licensed to practice medicine in Texas, Ohio, and New Mexico. He is affiliated with USMD Hospital at Arlington and Texas Health Harris Methodist Hospital Fort Worth.

Education & Training

  • University of Colorado
    University of ColoradoResidency, Internal Medicine, 1986 - 1988
  • University of Colorado School of Medicine Anschutz Medical Campus
    University of Colorado School of Medicine Anschutz Medical CampusClass of 1985

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1986 - 2025
  • TX State Medical License
    TX State Medical License 1993 - 2025
  • OH State Medical License
    OH State Medical License 2018 - 2021
  • OK State Medical License
    OK State Medical License 2015 - 2021
  • NM State Medical License
    NM State Medical License 2015 - 2019
  • WI State Medical License
    WI State Medical License 1990 - 1993
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • New USMD Cancer Care and Infusion Centers Open to Improve Cancer Care in Dallas-Fort Worth
    New USMD Cancer Care and Infusion Centers Open to Improve Cancer Care in Dallas-Fort WorthMay 20th, 2021
  • 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
    180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to StockholdersMarch 24th, 2021
  • Fusion Transcript Discovery Using RNA Sequencing in Formalin-Fixed Paraffin-Embedded Specimen
    Fusion Transcript Discovery Using RNA Sequencing in Formalin-Fixed Paraffin-Embedded SpecimenMarch 20th, 2021